Company Overview of Archemix Corp.
Archemix Corp., a biotechnology company, discovers, develops, and commercializes therapeutic aptamers for the prevention and treatment of chronic and acute diseases in Massachusetts. Its aptamer product candidates include ARC1779 for thrombotic microangiopathyies and carotid endarterectomy surgical procedure. The company also offers product candidates for cardiovascular, hematology, and oncology diseases. Archemix Corp. was incorporated in 2000 and is based in Cambridge, Massachusetts.
148 Sidney Street
Cambridge, MA 02139
Founded in 2000
Key Executives for Archemix Corp.
Similar Private Companies By Industry
|Cellerant Therapeutics, Inc.||United States|
|Catalyst Biosciences, Inc.||United States|
|SpringLeaf Therapeutics, Inc.||United States|
|Center Of Research Technology & Entrepreneurial Expertise||United States|
|Meryx Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Archemix Corp., please visit www.archemix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.